Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The type 9 adenylyl cyclase (
AC9
) is a widely distributed adenylyl cyclase that was originally cloned from a mouse cDNA library. Here we report the cloning, chromosomal mapping, and regulatory properties of human
AC9
(HGMW-approved symbol ADCY9). Although the human
AC9
sequence shows 86% homology with mouse
AC9
, divergence at the C2a/C2b junction results in an alternative C2b amino acid sequence. In situ hybridization localized the human
AC9
gene to both human and mouse chromosomes 16.
AC9
mRNA is present in all tissues examined, with the highest levels found in skeletal muscle, heart, and brain. To characterize the regulatory properties of human
AC9
in vivo, the enzyme was expressed in HEK-293 cells. Human
AC9
is stimulated by beta-adrenergic receptor activation but is insensitive to forskolin, Ca2+ and
somatostatin
. In contrast to mouse
AC9
, the activity of human
AC9
is unaffected by inhibitors of calcineurin. These data emphasize the importance of determining the regulatory properties of human adenylyl cyclases.
...
PMID:Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9). 962 27